Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
4
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
0 competitors in Chronic Obstructive Pulmonary Disease
View Full LandscapeTarget Indication
Chronic Obstructive Pulmonary Disease
Clinical Trial
NCT00929110Last updated: 3/17/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Sialanar
Symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.
View on EMATovanor Breezhaler
Tovanor Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
View on EMASeebri Breezhaler
Seebri Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
View on EMAEnurev Breezhaler
Enurev Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
View on EMA